Brochure | February 3, 2026

Proven Expertise And Customized End-To-End Solutions For Your Products

GettyImages-2183428971-lab-cleanroom

Advancing global health requires a seamless transition from initial process development to large-scale commercial manufacturing. Navigating the complexities of viral vectors, vaccines, and recombinant proteins demands a partner capable of managing the entire lifecycle of a biologic. With deep expertise in diverse modalities—including AAV, lentivirus, and oncolytic viruses—technical teams can leverage established cell lines and flexible manufacturing scales, from 200L to 2,000L, to accelerate speed-to-market.

Precision in aseptic fill/finish remains critical, utilizing high-speed automated lines capable of processing up to 32,000 vials per hour alongside specialized lyophilization and secondary packaging solutions. Supported by in-house analytical services and a robust regulatory track record with the FDA and EMA, these integrated services ensure every batch meets stringent quality standards. Explore how end-to-end expertise in sterile injectables and advanced therapies can empower your next project.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma